These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 28434046)
1. Oral arginine supplementation protects female mice from the onset of non-alcoholic steatohepatitis. Sellmann C; Degen C; Jin CJ; Nier A; Engstler AJ; Hasan Alkhatib D; De Bandt JP; Bergheim I Amino Acids; 2017 Jul; 49(7):1215-1225. PubMed ID: 28434046 [TBL] [Abstract][Full Text] [Related]
2. Supplementation of sodium butyrate protects mice from the development of non-alcoholic steatohepatitis (NASH). Jin CJ; Sellmann C; Engstler AJ; Ziegenhardt D; Bergheim I Br J Nutr; 2015 Dec; 114(11):1745-55. PubMed ID: 26450277 [TBL] [Abstract][Full Text] [Related]
3. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD). Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089 [TBL] [Abstract][Full Text] [Related]
4. Oral Supplementation of Glutamine Attenuates the Progression of Nonalcoholic Steatohepatitis in C57BL/6J Mice. Sellmann C; Baumann A; Brandt A; Jin CJ; Nier A; Bergheim I J Nutr; 2017 Nov; 147(11):2041-2049. PubMed ID: 28931589 [No Abstract] [Full Text] [Related]
5. Oral Glutamine Supplementation Protects Female Mice from Nonalcoholic Steatohepatitis. Sellmann C; Jin CJ; Degen C; De Bandt JP; Bergheim I J Nutr; 2015 Oct; 145(10):2280-6. PubMed ID: 26246326 [TBL] [Abstract][Full Text] [Related]
6. Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis. Baumann A; Jin CJ; Brandt A; Sellmann C; Nier A; Burkard M; Venturelli S; Bergheim I Nutrients; 2020 Mar; 12(4):. PubMed ID: 32235497 [TBL] [Abstract][Full Text] [Related]
7. Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function. Brandt A; Nier A; Jin CJ; Baumann A; Jung F; Ribas V; García-Ruiz C; Fernández-Checa JC; Bergheim I Redox Biol; 2019 Feb; 21():101092. PubMed ID: 30605883 [TBL] [Abstract][Full Text] [Related]
8. Loss of lipopolysaccharide-binding protein attenuates the development of diet-induced non-alcoholic fatty liver disease in mice. Jin CJ; Engstler AJ; Ziegenhardt D; Bischoff SC; Trautwein C; Bergheim I J Gastroenterol Hepatol; 2017 Mar; 32(3):708-715. PubMed ID: 27404046 [TBL] [Abstract][Full Text] [Related]
9. Treatment with alpha-galactosylceramide protects mice from early onset of nonalcoholic steatohepatitis: Role of intestinal barrier function. Engstler AJ; Sellmann C; Jin CJ; Brandt A; Herz K; Priebs J; Bergheim I Mol Nutr Food Res; 2017 May; 61(5):. PubMed ID: 28067024 [TBL] [Abstract][Full Text] [Related]
11. Short-Term Intake of a Fructose-, Fat- and Cholesterol-Rich Diet Causes Hepatic Steatosis in Mice: Effect of Antibiotic Treatment. Brandt A; Jin CJ; Nolte K; Sellmann C; Engstler AJ; Bergheim I Nutrients; 2017 Sep; 9(9):. PubMed ID: 28906444 [TBL] [Abstract][Full Text] [Related]
12. Preventive effects of citrulline on Western diet-induced non-alcoholic fatty liver disease in rats. Jegatheesan P; Beutheu S; Freese K; Waligora-Dupriet AJ; Nubret E; Butel MJ; Bergheim I; De Bandt JP Br J Nutr; 2016 Jul; 116(2):191-203. PubMed ID: 27197843 [TBL] [Abstract][Full Text] [Related]
13. Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase. Rajcic D; Baumann A; Hernández-Arriaga A; Brandt A; Nier A; Jin CJ; Sánchez V; Jung F; Camarinha-Silva A; Bergheim I Redox Biol; 2021 May; 41():101879. PubMed ID: 33550112 [TBL] [Abstract][Full Text] [Related]
14. Alterations of nitric oxide homeostasis as trigger of intestinal barrier dysfunction in non-alcoholic fatty liver disease. Baumann A; Rajcic D; Brandt A; Sánchez V; Jung F; Staltner R; Nier A; Trauner M; Staufer K; Bergheim I J Cell Mol Med; 2022 Feb; 26(4):1206-1218. PubMed ID: 35029027 [TBL] [Abstract][Full Text] [Related]
15. Short- and Long-Term Soy Diet Versus Casein Protects Liver Steatosis Independent of the Arginine Content. Hakkak R; Zeng H; Dhakal IB; Korourian S J Med Food; 2015 Nov; 18(11):1274-80. PubMed ID: 26186426 [TBL] [Abstract][Full Text] [Related]
16. Fortifying Butterfat with Soybean Oil Attenuates the Onset of Diet-Induced Non-Alcoholic Steatohepatitis and Glucose Intolerance. Sánchez V; Brandt A; Jin CJ; Rajcic D; Engstler AJ; Jung F; Nier A; Baumann A; Bergheim I Nutrients; 2021 Mar; 13(3):. PubMed ID: 33809593 [TBL] [Abstract][Full Text] [Related]
17. Protective effect of salvianolic acid B on NASH rat liver through restoring intestinal mucosal barrier function. Wang YC; Jin QM; Kong WZ; Chen J Int J Clin Exp Pathol; 2015; 8(5):5203-9. PubMed ID: 26191218 [TBL] [Abstract][Full Text] [Related]
18. Diets rich in fructose, fat or fructose and fat alter intestinal barrier function and lead to the development of nonalcoholic fatty liver disease over time. Sellmann C; Priebs J; Landmann M; Degen C; Engstler AJ; Jin CJ; Gärttner S; Spruss A; Huber O; Bergheim I J Nutr Biochem; 2015 Nov; 26(11):1183-92. PubMed ID: 26168700 [TBL] [Abstract][Full Text] [Related]
19. Lack of liver steatosis in germ-free mice following hypercaloric diets. Kaden-Volynets V; Basic M; Neumann U; Pretz D; Rings A; Bleich A; Bischoff SC Eur J Nutr; 2019 Aug; 58(5):1933-1945. PubMed ID: 29926176 [TBL] [Abstract][Full Text] [Related]
20. Citrulline decreases hepatic endotoxin-induced injury in fructose-induced non-alcoholic liver disease: an ex vivo study in the isolated perfused rat liver. Ouelaa W; Jegatheesan P; M'bouyou-Boungou J; Vicente C; Nakib S; Nubret E; De Bandt JP Br J Nutr; 2017 Jun; 117(11):1487-1494. PubMed ID: 28637520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]